Completed PHASE4 INTERVENTIONAL 2-arm NCT02350985

Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine

Effectivity of Propranolol and Venlafaxine in Treatment of Vestibular Migraine: A Randomized Controlled Clinical Trial

Sponsor: Haseki Training and Research Hospital

Updated 6 times since 2017 Last updated: Jan 29, 2015 Started: Jan 31, 2014 Primary completion: Sep 30, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02350985, this PHASE4 trial focuses on Vestibular Migraine and remains completed. Sponsored by Haseki Training and Research Hospital, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Haseki Training and Research Hospital

Data source: Haseki Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Istanbul, Turkey (Türkiye)